Sannova Analytical Inc.

What Sannova Analytical Inc. does

Sannova Analytical Inc. is a privately held US-based contract research organization (CRO) that provides bioanalytical and analytical testing services to pharmaceutical, biotechnology, and medical device developers. Operating from a 21,000+ square foot laboratory in Somerset, New Jersey, the company supports drug programs from preclinical through clinical (Phase I–IV) and into CMC analytical and commercial release work. The service portfolio spans bioanalytical method development and validation (PK/TK, DMPK, immunogenicity and ligand binding assays), analytical characterization (molecular weight, structure, purity, stability), CMC/QC testing, nitrosamine and elemental impurity analysis, extractables and leachables, stability storage, and specialized cell & gene therapy, biologics/biosimilars, quantitative proteomics, and biomarker discovery services. The firm serves 168 active customers worldwide and reports 1,300+ completed studies, 300+ validated methods, 360,000 annual sample capacity, and a 90%+ ISR pass rate.

The business is differentiated by a proprietary "Z-Factor Approach" quality methodology and by investment in differentiated instrumentation including Trapped Ion Mobility Spectrometry (TIMS), LC/MS/MS, ICP/MS, and Thermo Orbitrap Exploris HRMS, enabling work on complex therapeutics such as proteins, antibodies, nucleic acids, and gene therapies under GLP/GMP compliant practices aligned with FDA, EMA, and ICH requirements. Sannova generates revenue through professional-services CRO contracts priced on a quote basis, with a sales motion based on direct scientific consultation targeting both large pharma seeking overflow capacity and emerging/virtual biotech and medical device companies that lack internal analytical infrastructure. The company received investment from SFW Capital Partners in August 2022 to fund service expansion and strategic acquisitions, and is led by President & CEO Malleswar Rao Kollu.

Name

Sannova Analytical Inc.

Legal name

Sannova Analytical LLC

Website

https://sannova.net

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Sannova Analytical is a US-based boutique bioanalytical and analytical CRO serving pharmaceutical, biotechnology, and medical device developers from a Somerset, New Jersey laboratory, delivering PK/TK, DMPK, immunogenicity, CMC, nitrosamine, extractables/leachables, proteomics, biomarker, and cell & gene therapy testing under GLP/GMP standards.

Ownership category

akta.pro rank

Product category

Bioanalytical Contract Research Services

NAICS

Testing Laboratories and Services (54138), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)

Keywords

• Bioanalytical CRO services
• Pharmaceutical analytical testing
• CMC analytical services
• Mass spectrometry testing
• Preclinical drug development

Headquarters

HQ city

Somerset

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Contract Research Services: Full-service analytical and bioanalytical CRO providing end-to-end support for pharmaceutical development programs including method development, validation, sample analysis, and regulatory compliance services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Sannova Analytical is a boutique contract research organization (CRO) providing end-to-end bioanalytical and analytical services for pharmaceutical, biotechnology, and medical device companies. The company delivers method development, validation, sample analysis, and regulatory-compliant testing for small molecules, biologics, biosimilars, cell and gene therapies, and complex therapeutics using advanced mass spectrometry platforms including TIMS, LC/MS/MS, and ICP/MS. Services span preclinical through CMC analytical phases, with a proprietary Z-Factor Approach emphasizing quality, speed, and flexibility.

Product overview

Sannova Analytical Inc. is a boutique Contract Research Organization (CRO) offering comprehensive bioanalytical and analytical CRO services organized as an integrated portfolio of specialized testing services. The core offerings include Bioanalytical CRO Services, Preclinical Studies, PK Testing, DMPK Services, Immunogenicity and Ligand Binding, In Vitro Services, Analytical CRO Services, Analytical CMC and QC, Nitrosamines and Elemental Impurities Testing, Extractables and Leachables Testing, and Pharmaceutical Stability Testing. These services are organized by molecule type (Small Molecules, Biologics & Biosimilars, Cell & Gene Therapies, Biomarker Discovery, Quantitative Proteomics, Bioconjugates) and research phase (Drug Development and Discovery, Drug Manufacturing). The company serves the Pharmaceuticals, Biotechnology, and Medical Devices industries. All services are delivered using a Z-Factor Approach methodology for quality assurance, with facilities in New Jersey spanning 21,000+ square feet equipped with advanced instrumentation including TIMS, LC/MS/MS, ICP/MS, and HRMS platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioanalytical CRO Services Comprehensive bioanalytical laboratory services for pharmaceutical development including PK research, DMPK, TK studies, immunogenicity assays, and high-resolution mass spectrometry for preclinical and clinical sample analysis. Targets pharma and biotech R&D teams.
• Preclinical Studies Bioanalytical preclinical CRO services evaluating drug safety, efficacy, and suitability in animal matrices to determine dosages, identify side effects, and ensure regulatory compliance before clinical trials. For pharma and biotech preclinical programs.
• PK Testing Pharmacokinetic testing services using advanced analytical platforms to quantify drug concentrations and characterize concentration-time profiles, supporting dosing optimization and development decisions. For pharma/biotech development teams.
• DMPK Services Drug metabolism and pharmacokinetics testing services providing in vitro assays and in vivo studies to understand biotransformation and ADME behavior of drug compounds. For pharma R&D programs.
• Immunogenicity and Ligand Binding Bioanalytical services assessing immune responses and monitoring drug-target interactions using electrochemiluminescence and ligand binding assays for biologics and biosimilars. For biologics developers.
• In Vitro Services In vitro DMPK assays enabling understanding of drug compound efficacy and safety profiles using various biological matrices including simulated gastric fluids, aqueous humor, and surrogate membranes. For pharma R&D.
• Analytical CRO Services Analytical characterization services determining molecular weight, structure, concentration, purity, reactivity, and stability using HPLC systems, particle size analyzers, and ICP-MS instruments. For pharma and biotech product characterization.
• Analytical CMC and QC Chemistry, Manufacturing and Controls analytical services supporting CMC projects with ion chromatography, osmolality, particle size determination, rheology, viscosity, and residual solvents testing. For drug development and manufacturing teams.
• Nitrosamines and Elemental Impurities Testing Elemental impurities and nitrosamine testing services using ICP-MS and LC/MS methods to detect trace levels of probable human carcinogens and metal impurities as per regulatory standards. For pharma quality control.
• Extractables and Leachables Testing Extractables and leachables (E&L) testing services identifying and quantifying potential compounds migrating from packaging materials using LC/MS/MS, GC-HS-FID/MS, and ICP/MS techniques. For pharma packaging and medical device programs.
• Pharmaceutical Stability Testing Pharmaceutical stability testing services evaluating drug behavior under various conditions over time using ICH-compliant stability chambers to determine shelf life and ensure product safety. For pharma development and manufacturing.
• Cell & Gene Therapy Services Specialized bioanalytical and analytical services for cell and gene therapy development including assay development, sample analysis, and regulatory support for PCR and mRNA technologies. For cell/gene therapy developers.
• Biologics & Biosimilars Services Analytical services for biologics and biosimilars characterization including assay development, sample analysis, and regulatory support for monoclonal antibodies and protein therapeutics. For biologics developers.
• Quantitative Proteomics Quantitative proteomics services providing precise analysis of protein expression, modifications, and interactions using trapped ion mobility spectrometry (TIMS) and advanced mass spectrometry techniques. For proteomics research teams.
• Biomarker Discovery Biomarker discovery and validation services developing and validating assays for measuring biomarkers in biological samples to support disease diagnosis and treatment monitoring. For translational research and clinical programs.

Quantifiable outcome

• 90%+ ISR pass rate demonstrating data reliability
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Frontage Laboratories: PE-backed bioanalytical and CMC analytical CRO with similar service mix (DMPK, PK, biologics, biomarker) and a comparable boutique-to-mid-market positioning. Closest publicly traded comparable for Sannova's business model and growth trajectory.
• Bioanalytical Systems (BASi): Long-standing boutique bioanalytical CRO providing PK/TK, ADME, and analytical services to pharma and biotech. Comparable scale, similar customer mix, and overlapping small-molecule and biologics capabilities make BASi a near-direct peer.
• WuXi AppTec: Global CRO/CDMO with large bioanalytical and CMC analytical service lines spanning small molecules, biologics, and cell/gene therapy. Closest peer in modality coverage to Sannova and the most aggressive low-cost competitor in the U.S. market.

Broad incumbents

• Charles River Laboratories: Global CRO offering discovery, safety assessment, bioanalytical, and manufacturing services. Overlaps with Sannova in bioanalytical, preclinical, and CMC testing but at vastly larger scale and broader portfolio.
• Labcorp Drug Development (formerly Covance): One of the largest global CROs with full-service bioanalytical, clinical, and central laboratory capabilities. Competes for overflow bioanalytical work from Sannova's pharma clients and sets the price floor for premium bioanalytical services.
• IQVIA: Largest global CRO with significant bioanalytical and clinical laboratory operations integrated with data/analytics. Represents the upper bound of competitive pressure on boutique CRO pricing and contract size.
• PPD (Thermo Fisher Scientific): Global clinical and bioanalytical CRO now part of Thermo Fisher. Competes for the same preclinical-to-clinical bioanalytical contracts that Sannova targets, particularly from mid-sized pharma clients.
• ICON plc: Major global CRO with bioanalytical and laboratory services across the drug development lifecycle. Directly comparable on the bioanalytical/PK service line, though at substantially larger scale and global footprint.
• Eurofins Scientific: Global testing services group with significant bioanalytical, pharmaceutical, and CMC analytical laboratory offerings across the U.S. and Europe. Overlaps directly with Sannova's analytical CRO and stability testing lines.
• Syneos Health: Clinical and bioanalytical CRO serving pharma and biotech across the development lifecycle. Competes with Sannova for clinical-phase bioanalytical work and increasingly for cell/gene therapy programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/sannovacro
• LinkedInlinkedin.com/company/sannova-analytical-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sannova Analytical Inc.